The 21st Century Cures Act: pharmacoeconomic boon or bane?
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Medical Economics"
DOI: 10.1080/13696998.2017.1282865
Abstract: Abstract Barriers to entry in healthcare markets constitute one of the overriding concerns of health economists. The recent enactment of the 21st Century Cures Act in the United States reduces statutory entry barriers to the… read more here.
Keywords: 21st century; century cures; act pharmacoeconomic; cures act ... See more keywords